Ultralife

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ultralife reports record sales in Q4 2022 amidst challenges

Ultralife Corporation delivered robust financial results in Q4 2022, showcasing growth in sales, segments, and profitability, despite facing challenges like supply chain disruptions and cybersecurity incidents.
The company's strategic strengths in market focus, operational resilience, and debt reduction plans position it well to capitalize on opportunities for further growth and innovation in the future.
Analysts' inquiries highlighted areas for improvement and risk mitigation, signaling a proactive approach by Ultralife to address challenges and drive sustainable value creation.

Ultralife reports revenue growth amidst cyber attack challenges in Q1

Ultralife resilient in Q1 2023 with revenue growth despite cyber attack impact.
Strong government defense sales offset commercial sales decline.
Company focused on executing backlog, improving margins, and driving growth.
Challenges include cyber incident impact, net loss, and supply chain issues.

Ultralife reports stellar Q2 results, eyes margin improvement and growth

Ultralife Corporation delivered exceptional Q2 2023 results, marked by substantial revenue growth, profitability, and a record backlog, showcasing strong market demand.
The company's focus on improving gross margins, efficient cost management, and growth initiatives in key segments positions it well for future success and market leadership.
While challenges like maintaining margins and executing backlog exist, Ultralife's solid financial performance, operational stability, and growth opportunities paint a positive outlook.
By leveraging opportunities for margin enhancement, market expansion, and innovation, Ultralife can navigate challenges and capitalize on its strengths for sustained growth and profitability.

Ultralife reports robust Q3 performance, eyes growth through strategic initiatives

Ultralife's Q3 2023 performance reflects strong financial health, with notable improvements in gross margin, operating profit, and revenue growth.
The company's strategic focus on debt reduction, profitability enhancement, and organic growth initiatives underscores a promising outlook for future success.
Challenges lie in consistently improving gross margins, maintaining backlog levels, and effectively balancing debt repayment with growth investments.

Ultralife (ULBI) posts strong Q4 results, eyes growth opportunities

Ultralife (ULBI) delivered robust financial performance in Q4 and full-year 2023, driven by strong sales growth and margin improvement.
The company faces challenges in production capacity, operational efficiency, and project launches, requiring ongoing attention.
Strategic focus on gross margin enhancement, organic growth, and new product opportunities present avenues for future expansion.
With a solid financial position, Ultralife is well-positioned to capitalize on market opportunities and navigate potential challenges.

Ultralife reports robust Q1 earnings, poised for strategic growth

Ultralife Corporation's Q1 2024 performance reflects strong revenue growth, margin improvement, and profitability milestones.
The company's focus on key segments like Battery & Energy Products and Communication Systems drove significant revenue increases.
While challenges like sustaining margins and managing expenses exist, Ultralife is well-positioned to capitalize on growth opportunities.
Investors should take note of Ultralife's turnaround in earnings and strategic positioning for future growth.

Ultralife posts robust Q2 results, eyes M&A opportunities amid challenges

Ultralife's Q2 performance showcased strong sales, debt reduction, and margin improvement.
While facing challenges in the Communications Systems segment, the company's strategic focus on debt management and market diversification presents growth opportunities.
Investors should take note of Ultralife's solid financial position and potential for future expansion through M&A.

Ultralife reports mixed Q3 results, eyes growth through Electrochem acquisition

Ultralife's Q3 performance reflects mixed results with revenue growth in Battery & Energy Products but decline in Communication Systems.
The company faces challenges in revenue diversification, margin pressure, and increased operating expenses.
However, strategic initiatives and the Electrochem acquisition offer growth opportunities in high-reliability markets.
Overall, Ultralife's focus on efficiency and profitability amidst challenges positions it for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ultralife Corporation (ULBI) CEO Mike Popielec on Q2 2021 Results - Earnings Call Transcript

NEWARK, N.Y., July 15, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2021 before the market opens on Thursday, July 29, 2021.

Ultralife Corporation to Report Second Quarter Results on July 29, 2021

The stock price of Ultralife Corp. (NASDAQ: ULBI) increased by over 25% pre-market. This is why it happened.

Ultralife (ULBI) Stock: Over 25% Increase Pre-Market Explanation

NEWARK, N.Y., May 17, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price indefinite-delivery/indefinite-quantity contract from the U.S. Army for purchases of Conformal Wearable Batteries not to exceed $168 million during the three-year base award period with the potential for up to an additional $350 million should the six one-year option periods be exercised. The timing of deliveries and quantities are at the discretion of the U.S. Army, and include successful completion of First Article Testing demonstrating full compliance with the contractual product specifications and program requirements.

Ultralife Corporation Awarded IDIQ Contract Under U.S. Army's $1.25B Conformal Wearable Battery Program

Ultralife Corporation's (ULBI) CEO Mike Popielec on Q1 2021 Results - Earnings Call Transcript

Ultralife's (ULBI) CEO Mike Popielec on Q4 2020 Results - Earnings Call Transcript

NEWARK, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2020 before the market opens on Thursday, February 4, 2021.

Ultralife Corporation to Report Fourth Quarter Results on February 4, 2021

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial news websites. However, in this article we will take a look at their collective moves over the last 5 years and analyze what the smart money thinks of Ultralife Corp. (NASDAQ:ULBI) based on that data.

Is Ultralife Corp. (ULBI) A Good Investment Right Now?

Ultralife Corporation's (ULBI) CEO Michael Popielec on Q3 2020 Results - Earnings Call Transcript

NEWARK, N.Y., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2020 before the market opens on Thursday, October 29, 2020.

Ultralife Corporation to Report Third Quarter Results on October 29, 2020  

Ultralife Corporation's (ULBI) CEO Michael Popielec on Q2 2020 Results - Earnings Call Transcript

NEWARK, N.Y., July  16, 2020  (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2020 before the market opens on Thursday, July 30, 2020.

Ultralife Corporation to Report Second Quarter Results on July 30, 2020

NEWARK, N.Y., July  07, 2020  (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:  ULBI) today announced that due to the ongoing public health impact of the coronavirus (COVID-19) pandemic and out of an abundance of caution, the location of the Annual Meeting of Shareholders to be held on July 22nd at 9:00 AM Eastern Time will be changed to the Newark, NY headquarters of Ultralife located at 2000 Technology Parkway, Newark, NY 14513.  The Meeting was originally scheduled to be held at The Westin Crystal City in Arlington, VA.  Except for the change in location, all other details of the Annual Meeting, including the proposals to be voted at the Meeting, remain unchanged.

Ultralife Corporation Announces Change in Location of Annual Meeting of Shareholders

NEWARK, N.Y., June  29, 2020  (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:  ULBI) today announced it has been added to the Russell 2000® Index as part of the 2020 Russell U.S. Indexes annual reconstitution, effective as the U.S. market opens today.

Ultralife Corporation Announces Addition to the Russell 2000® Index

Ultralife's (ULBI) CEO Mike Popielec on Q1 2020 Results - Earnings Call Transcript

NEWARK, N.Y., March  25, 2020  (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:  ULBI) today issued a letter to its employees, customers, suppliers, and shareholders regarding its business operations amid the COVID-19 pandemic.

Ultralife Corporation Issues Letter to Stakeholders Regarding Business Operations in Response to COVID-19  

Ultralife Corporation (ULBI) CEO Mike Popielec on Q4 2019 Results - Earnings Call Transcript

NEWARK, N.Y., Dec.  18, 2019  (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a $4.9 million firm-fixed price delivery contract from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5390 batteries. Shipments are expected to commence and be completed in 2020.

Ultralife Corporation Receives Award for Its Legacy BA-5390 Military Batteries from Defense Logistics Agency

Ultralife Corporation (ULBI) CEO Mike Popielec on Q3 2019 Results - Earnings Call Transcript

NEWARK, N.Y., Sept.  19, 2019  (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $14.4 million from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5368 batteries. These batteries are used in a variety of military applications, including detectors and imaging. The award consists of a three-year base contract with two one-year option periods.  The amounts and timing of deliveries under this contract are at the discretion of the DLA.

Ultralife Corporation Receives $14.4 Million IDIQ Award from Defense Logistics Agency for BA-5368 Military Batteries

Ultralife Corp. (ULBI) CEO Mike Popielec on Q1 2019 Results - Earnings Call Transcript

News for Ultralife Stock (ULBI)